FDA Drug Topics: An Overview of FDA’s Project Facilitate Oncology Expanded Access Program - December 12, 2023
FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurse practitioners, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!
On Tuesday, December 12, 2023, CDER's Office of Communication, Division of Drug Information (DDI) will host a webinar titled: FDA Drug Topics: An Overview of FDA’s Project Facilitate Oncology Expanded Access Program. Expanded access, sometimes called "compassionate use", is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available. This webinar will review the oncology expanded access pathway and Project Facilitate's role in making oncology expanded access more accessible for healthcare and regulatory professionals.
Register Here: https://fda.zoomgov.com/webinar/register/WN_65SY0ANjSNmnDJ3sd8OODg
Download Presentation Slides: An Overview of FDA’s Project Facilitate Oncology Expanded Access Program (PDF - 4.32 MB)
Activity Outline and Continuing Education Information
Resources